BHV-4157

DRUG2 trials

Sponsors

University of California, Los Angeles, Biohaven Therapeutics Ltd.

Conditions

MSA-CSpinocerebellar Ataxia 3Spinocerebellar Ataxia Type 1Spinocerebellar Ataxia Type 2Spinocerebellar Ataxia Type 6Spinocerebellar Ataxias

Phase 3

Open Pilot Trial of BHV-4157

Active, not recruitingNCT03408080

University of California, Los AngelesMSA-C, Spinocerebellar Ataxia 3, Spinocerebellar Ataxias +3

Start: 2017-12-15End: 2024-12-15Target: 24Updated: 2024-05-09

Unknown Phase

Real-World Data Study of Troriluzole-Treated Patients With Spinocerebellar Ataxia (SCA) Compared to a Matched Natural History Control

Active, not recruitingNCT06529146

Biohaven Therapeutics Ltd.Spinocerebellar Ataxias

Start: 2019-03-18End: 2026-08-01Updated: 2026-06-09